Feb 7 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST :
* KLARIA RECEIVES 6.4 MSEK MILESTONE PAYMENT FROM EU'S
HORIZON
2020 PROGRAM TO TAKE SUMATRIPTAN ALGINATE FILM TO MARKET
* KLARIA PHARMA HOLDING AB (PUBL) - PIVOTAL CLINICAL STUDY
REQUIRED FOR SUBMISSION OF APPROVAL IS PLANNED TO START IN FIRST
HALF OF 2020
* KLARIA PHARMA HOLDING AB (PUBL) - MILESTONE PAYMENT OF 6.4
MSEK
IS EXPECTED TO COVER REMAINING COSTS WITHIN KL-00119 PROJECT UP
UNTIL FILING OF APPLICATIONS FOR MARKET APPROVAL
Source text for Eikon: ID:nWkr6XJsNT
Further company coverage: KLAR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))